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ABSTRACT
Background: Injury to the spleen is a recognized com-
plication during percutaneous renal access due to the
close anatomical relationship of the spleen and the left
kidney. However, transsplenic renal access is a rare com-
plication of percutaneous nephrolithotomy and can also
result in considerable morbidity, often requiring emergent
splenectomy.
Methods: We present our experience with splenic injury
during percutaneous nephrolithotomy managed conser-
vatively with the use of a collagen-thrombin hemostatic
sealant (D-Stat; Vascular Solutions, Inc., Minneapolis, MN)
after delayed removal of the nephrostomy tubes.
Results: The patient had an uneventful recovery and was
discharged home on postoperative day 6.
Conclusion: In select hemodynamically stable patients,
nonoperative management with the adjunctive use of he-
mostatic sealants may be considered.
Key Words: Splenic injury, Percutaneous nephrolithot-
omy, Nonoperative management.
INTRODUCTION
Percutaneous nephrolithotomy (PCNL) has become the
standard of care for large and complex renal calculi, dem-
onstrating excellent stone clearance rates with acceptable
morbidity in most patients.1 Although some reviews note
overall high complication rates with PCNL,2 the majority
of morbidity is related to percutaneous renal access and
can be managed conservatively without significant se-
quelae. Major complications requiring intervention during
PCNL occur in 0.9% to 4.7% of cases,1–3 and include
bleeding, sepsis, and injury to adjacent viscera. Injuries to
the lung, pleura, liver, colon, duodenum, and spleen have
been reported during percutaneous access to the kid-
ney.4,5 Due to the close anatomic relationship of the left
kidney and the spleen, iatrogenic splenic injuries are as-
sociated with renal surgery and percutaneous access;
however, splenic injuries during PCNL are uncommon.6–9
The early diagnosis and treatment of splenic injuries can
prevent associated morbidity and mortality, as missed
splenic injuries are potentially fatal.10 Some authors advo-
cate the management of splenic injuries during PCNL with
emergent exploratory laparotomy and splenectomy.2 We
describe a case of iatrogenic splenic injury during PCNL,
resulting from transsplenic renal access and tract dilation,
managed conservatively with the use of a collagen-throm-
bin hemostatic sealant.
CASE REPORT
A 33-year-old woman was discovered to have a large left
staghorn calculus on investigation of lower back pain with
recurrent Proteus urinary tract infections. Her past medical
history was otherwise notable for hypertension and mor-
bid obesity. A noncontrast CT of her abdomen revealed a
left staghorn calculus occupying the entire left renal pelvis
and calices. The patient elected to undergo a percutane-
ous nephrolithotomy and was admitted one day prior to
scheduled surgery to receive intravenous antibiotics.
Interventional radiology initially obtained renal access
through 3 nephrostomy tracts using fluoroscopic guid-
ance. The lower, middle, and upper pole calices were
accessed by using a 21-gauge needle, and 6-French py-
eloureteral catheters were advanced to the distal ureter
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CASE REPORTover glide wires. The patient then underwent PCNL, and
all 3 nephrostomy tracts were sequentially enlarged by
using a 30-French by 15-cm balloon dilating catheter
(Nephromax, Boston Scientific Corporation, Boston, MA).
The most inferior nephrostomy tract was dilated first,
followed by the mid and upper pole tracts. Bleeding
occurred after dilating the upper nephrostomy tract,
which was placed at the tenth posterior intercostal space.
After the majority of the patient’s stone burden was re-
moved, three 22-French nephrostomy catheters and a
double J ureteral stent were placed under fluoroscopic
guidance. The estimated blood loss from the procedure
was 750 mL. During the first 2 postoperative days, the
patient had continued hematuria and was anemic with a
hemoglobin of 6.0 g/dL. She was transfused a total of 6
units of packed red blood cells and otherwise remained
hemodynamically stable. A noncontrast CT scan to assess
any remaining stone burden revealed that the 2 upper
nephrostomy tubes traversed through the spleen (Figure
1A). Following consultation with the general surgery ser-
vice, the patient underwent continued observation as she
remained hemodynamically stable and did not require any
further blood products. The patient continued on bed rest
in a monitored unit, with all 3 nephrostomy tubes in situ,
and her urine gradually cleared. The 3 nephrostomy tubes
were removed by interventional radiology on postopera-
tive day 4, at which time a collagen-thrombin hemostatic
sealant, D-Stat (Vascular Solutions, Inc., Minneapolis,
MN), was injected into the 2 upper nephrostomy tracts. A
repeat CT shortly after removal of the nephrostomy tubes
confirmed that no active bleeding or hematoma was
present. The patient otherwise made an uneventful recov-
ery and was discharged home on postoperative day 6. She
returned one month later for management of her residual
stone disease within the left kidney and underwent uret-
erorenoscopy and laser lithotripsy. Delayed imaging at 6
months revealed successful stone clearance without
perisplenic fluid collections (Figure 1B).
DISCUSSION
PCNL remains the treatment of choice for staghorn and
complex renal calculi and is generally well tolerated with
minimal morbidity.11 Although vascular complications are
reported with PCNL, injury to the spleen is rare. Due to the
close anatomical relationship of the spleen to the left
kidney, the risk of injury to the spleen during upper pole
renal access is increased.
While splenic injuries may present acutely with hemody-
namic instability, clinical signs and symptoms vary widely.
A heightened suspicion for vascular injuries or splenic
trauma in the perioperative period should be considered
in patients undergoing PCNL with excessive blood loss,
hemodynamic instability, or severe abdominal pain. In
our patient, splenic injury resulted from initial percutane-
Figure 1. (A) Axial computed tomographic images after percu-
taneous nephrolithotomy to assess remaining stone burden,
which demonstrated transsplenic renal access with a nephros-
tomy catheter after percutaneous nephrolithotomy and (B) at
6-month follow-up demonstrating resolution of injury without
significant sequelae.
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phrostomy tract to 30 French. Occult splenic injuries may
be underreported and unrecognized, as CT imaging is not
routinely used postoperatively. We recommend CT imag-
ing in patients with excessive perioperative bleeding, be-
cause CT has a high specificity and sensitivity to facilitate
identification of splenic trauma or injury to surrounding
structures.12 However, prevention is the best management
of these complications. A careful review of preoperative
imaging could identify anatomical variants, such as
splenomegaly or a retrorenal colon or spleen.13 In these
complicated cases, the use of additional imaging modali-
ties such as ultrasound or CT guidance during initial per-
cutaneous renal access should be considered instead of
fluoroscopy to avoid potential injury to surrounding or-
gans.
Historically, the nonoperative management of splenic in-
juries was associated with a high mortality rate. However,
advances in imaging and new grading systems of splenic
injuries have allowed select patients to be successfully
managed conservatively, thus avoiding laparotomy and
splenectomy.14 Although the incidence of splenic injury
with percutaneous renal access is more common,6 splenic
injuries during PCNL are rare and have potential for sig-
nificant bleeding due to a larger dilation of the nephros-
tomy tract. The morbidity of such an injury would depend
on the number of attempts used to gain renal access as
well as the diameter and location of the nephrostomy tract
within the spleen. We reviewed reported cases of splenic
injury during PCNL and noted that a significant number of
cases were managed operatively (Table 1). Some authors
have recommended management with emergent laparot-
omy and splenectomy for splenic injuries2; however, a
nonoperative approach may be pursued in select hemo-
dynamically stable patients. These patients can be man-
aged with bed rest, close monitoring, and the placement
of large bore catheters to tamponade bleeding within the
nephrostomy tracts. Most importantly, early recognition of
such splenic injuries is vital to ensure adequate patient
resuscitation and to prepare for possible emergent sple-
nectomy if conservative management fails. In the present
case, the patient was closely observed after delayed re-
moval of the nephrostomy tubes with injection of a col-
lagen-thrombin hemostatic sealant (D-Stat; Vascular Solu-
tions, Inc., Minneapolis, MN) into the nephrostomy tracts.
These hemostatic agents have also been successfully uti-
lized as adjuncts to reduce bleeding from splenic injuries
during renal surgery,15,16 and have been shown to be safe
Table 1.
Literature Review of Splenic Injuries During Percutaneous Nephrolithotomy
Author (n) Management Outcome*
Kondás et al
7 1 Exploratory laparotomy/splenectomy Transfused 3 units PRBCs. Uneventful
recovery
Carey et al
8 1 Bed rest, delayed nephrostomy catheter
removal after 2 weeks
Uneventful recovery
Shah et al
6 2 1. Exploratory laparotomy/splenectomy 1. Transfused 4 units PRBCs. Uneventful
recovery
2. Exploratory laparotomy and
hemostasis with fibrin glue
2. EBL 2000 mL Transfused 3 units PRBCs.
Uneventful recovery
Schaeffer et al
9 3 1. Direct pressure over nephrostomy
tract followed by serial monitoring for 3
days
1. Perisplenic hematoma without further
active bleeding.
2. Discharge home with delayed
nephrostomy tube removal on
postoperative day 15
2. Uneventful recovery
3. Delayed nephrostomy tube removal
on postoperative day 12
3. Uneventful recovery
Current study 1 Bed rest, delayed nephrostomy catheter
removal after 4 days with injection of a
collagen-thrombin hemostatic sealant
into the nephrostomy tracts
EBL 750 mL. Transfused 6 units PRBCs.
Uneventful recovery
*PRBCs, packed red blood cells; EBL, estimated blood loss.
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nephrostomy catheters for ‘tubeless’ PCNL.17,18 Alternatively,
splenic artery angioembolization may be used as a nonop-
erative management of splenic bleeding in select cases.19
Repeat CT imaging can be performed to detect early signs
of active bleeding; however, emergent splenectomy is
warranted if conservative management fails or for patients
with evidence of hemodynamic instability.
CONCLUSION
The early recognition and management of splenic injuries
during PCNL is paramount to prevent potential morbidity
and mortality. Although patients may require emergent
laparotomy with splenectomy, hemodynamically stable
patients may be managed conservatively with close mon-
itoring, delayed removal of the nephrostomy catheters,
and with the adjunctive use of hemostatic sealants. Careful
patient selection is essential to determine suitable candi-
dates for this nonoperative paradigm.
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